These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27366678)

  • 21. Insulin-Like Growth Factor Binding Protein-Related Protein 1 Inhibit Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
    Zhang P; Wang H; Cao H; Xu X; Sun T
    J Ocul Pharmacol Ther; 2017; 33(6):459-465. PubMed ID: 28402720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
    Barnett JM; McCollum GW; Fowler JA; Duan JJ; Kay JD; Liu RQ; Bingaman DP; Penn JS
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):907-15. PubMed ID: 17251494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression.
    Cheng G; Tian K; Zhang L; Yang N; Xing Y; He T
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):97-108. PubMed ID: 26358273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1α-VEGF pathway in oxygen-induced retinopathy mice.
    Xu Y; Lu X; Hu Y; Yang B; Tsui CK; Yu S; Lu L; Liang X
    J Pineal Res; 2018 May; 64(4):e12473. PubMed ID: 29411894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PF4 antagonizes retinal neovascularization via inhibiting PRAS40 phosphorylation in a mouse model of oxygen-induced retinopathy.
    Cai S; Yang Q; Cao Y; Li Y; Liu J; Wang J; Zhang X; Liu L; Li X; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165604. PubMed ID: 31740404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal Delivery of VEGF-A
    Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
    Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal and spatial changes in VEGF, αA- and αB-crystallin expression in a mouse model of oxygen-induced retinopathy.
    Shi Y; Su C; Wang JT; Du B; Dong LJ; Liu AH; Li XR
    Int J Clin Exp Med; 2015; 8(3):3349-59. PubMed ID: 26064225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small interference RNA targeting vascular endothelial growth factor gene effectively attenuates retinal neovascularization in mice model.
    Kong YC; Sun B; Zhao KX; Han M; Wang YC
    Chin Med J (Engl); 2013; 126(8):1440-4. PubMed ID: 23595374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
    Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Probenecid on Endothelial Cell Growth Rate and Retinal Angiogenesis in an Oxygen-Induced Retinopathy Model.
    Jiang J; Ou W; Luo X; Xiang J; Liu G; Huang S; Li H; He L; Gan J; Han S; Nie C
    Front Pharmacol; 2021; 12():717351. PubMed ID: 34690760
    [No Abstract]   [Full Text] [Related]  

  • 33. Suppression of Retinal Neovascularization by Anti-CCR3 Treatment in an Oxygen-Induced Retinopathy Model in Mice.
    Hirahara S; Nozaki M; Ohbayashi M; Hasegawa N; Ozone D; Ogura Y
    Ophthalmic Res; 2017; 58(1):56-66. PubMed ID: 28376500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
    Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
    Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy.
    Di Y; Zhang Y; Nie Q; Chen X
    Int J Mol Med; 2015 Dec; 36(6):1507-18. PubMed ID: 26459773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
    Saito Y; Geisen P; Uppal A; Hartnett ME
    Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.
    van Wijngaarden P; Brereton HM; Gibbins IL; Coster DJ; Williams KA
    Exp Eye Res; 2007 Oct; 85(4):508-17. PubMed ID: 17692314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy.
    Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA
    Wang Y; Wang Y; Wang X; Ma Y; Li Z; Di Y
    Front Med (Lausanne); 2022; 9():803214. PubMed ID: 35445044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.
    Leske DA; Wu J; Fautsch MP; Karger RA; Berdahl JP; Lanier WL; Holmes JM
    Mol Vis; 2004 Jan; 10():43-50. PubMed ID: 14758338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.